Little is known about metabolic regulation in stem cells and how this modulates tissue regeneration or tumour suppression. We studied the Lkb1 tumour suppressor and its substrate AMP-activated protein kinase (AMPK), kinases that coordinate metabolism with cell growth. Deletion of the Lkb1 (also called Stk11) gene in mice caused increased haematopoietic stem cell (HSC) division, rapid HSC depletion and pancytopenia. HSCs depended more acutely on Lkb1 for cell-cycle regulation and survival than many other haematopoietic cells. HSC depletion did not depend on mTOR activation or oxidative stress. Lkb1-deficient HSCs, but not myeloid progenitors, had reduced mitochondrial membrane potential and ATP levels. HSCs deficient for two catalytic a-subunits of AMPK (AMPK-deficient HSCs) showed similar changes in mitochondrial function but remained able to reconstitute irradiated mice. Lkb1-deficient HSCs, but not AMPK-deficient HSCs, exhibited defects in centrosomes and mitotic spindles in culture, and became aneuploid. Lkb1 is therefore required for HSC maintenance through AMPK-dependent and AMPK-independent mechanisms, revealing differences in metabolic and cell-cycle regulation between HSCs and some other haematopoietic progenitors.
Lkb1 coordinates cell growth with energy metabolism. Energy stress prompts Lkb1 to activate catabolic processes and mitochondrial biogenesis and to inactivate anabolic processes including mammalian target of rapamycin (mTOR)-mediated protein synthesis 1 . Lkb1 exerts these effects by activating AMPK and AMPK-related kinases 2 . AMPK activates the tuberous sclerosis complex (TSC), which inhibits mTOR complex 1 (mTORC1), reducing protein translation and cell growth 3, 4 . AMPK also inactivates mTORC1 by phosphorylating Raptor 5 . AMPK can promote the function of Foxo family transcription factors 6, 7 , which regulate energy metabolism, cell cycle, apoptosis and oxidative stress 8 .
Lkb1 regulates embryogenesis and the metabolism and polarity of differentiated adult cells. The Lkb1 homologue in Caenorhabditis elegans regulates embryo asymmetry 9 . Drosophila Lkb1 and AMPK regulate cell polarity, asymmetric division and mitotic spindle formation in embryos [10] [11] [12] . Mice deficient for Lkb1 die at mid-gestation with vascular and neural tube defects 13, 14 . In adult tissues, Lkb1 regulates the metabolism of muscle 15, 16 , liver 17 , pancreas [18] [19] [20] and T cells 21, 22 . Deletion of Lkb1 in mammalian neurons 23 , epithelial cells 24 and pancreatic b cells [18] [19] [20] disrupts their polarity or differentiation; however, Lkb1 is not known to regulate stem-cell maintenance or adult tissue regeneration.
Lkb1-deficiency increases the proliferation of many tissues 20, [25] [26] [27] and immortalizes mouse embryonic fibroblasts 28 . Lkb1 is mutated in Peutz-Jeghers syndrome patients 29, 30 , who have a high incidence of epithelial cancers 1 . These data suggest that the primary function of Lkb1 in adult tissues is to negatively regulate cell division, preventing tissue overgrowth. To test whether Lkb1 positively or negatively regulates stem-cell function we conditionally deleted Lkb1 from haematopoietic cells.
Deletion of Lkb1 depletes HSCs
Lkb1 messenger RNA was expressed at approximately twofold higher levels in HSCs (CD150 1 CD48 2 CD41 2 lineage (Lin) 2 Sca-1 1 c-Kit 1 ), transiently reconstituting multipotent progenitors (MPPs) (CD150 2 CD48 2 CD41 2 Lin 2 Sca-1 1 c-Kit 1 ) 31, 32 and granulocytemacrophage progenitors (GMPs; Lin 2 Sca-1 2 c-Kit 1 CD34 1 CD16/ 32 1 (ref. 33) ) as compared to whole bone marrow (WBM) cells by quantitative real-time PCR (qPCR) ( Supplementary Fig. 1d ).
We generated a floxed allele of Lkb1 (Lkb1 fl ) by gene-targeting in Bruce4 embryonic stem (ES) cells 34 ( Supplementary Fig. 1 ) then conditionally deleted Lkb1 from haematopoietic cells in adult Mx1-cre; Lkb1 fl/fl mice by injecting polyinosinic-polycytidylic acid (pIpC) 35, 36 ( Supplementary Fig. 1e , f). All control (Lkb1 fl/fl mice) and mutant (Mx1-cre; Lkb1 fl/fl ) mice were treated with three injections of pIpC over 6 days and the time of analysis is indicated in days after the first pIpC injection. We used a low dose of pIpC (0.5 mg per gram body mass) that was titrated to completely delete Lkb1 without significantly altering HSC surface marker phenotype or cell cycle kinetics.
Deletion of Lkb1 had little acute effect on the cellularity or composition of haematopoietic tissues 6-18 days after starting pIpC treatment ( Fig. 1a-d and Supplementary Fig. 2a -c). However, pancytopenia was observed by 24-34 days after pIpC treatment (Fig. 1a, e and Supplementary Fig. 2d -l). Two and six days after starting pIpC treatment, HSC frequency significantly increased (P , 0.0005) in pIpCtreated Mx1-cre; Lkb1 fl/fl mice compared to littermate controls ( Fig. 1f ). HSC frequency declined to one-seventh of normal levels in pIpC-treated Mx1-cre; Lkb1 fl/fl mice by 18 days after pIpC treatment (P , 0.0005; Fig. 1f ). MPPs transiently expanded and then were depleted in parallel with HSCs ( Supplementary Fig. 4c, d ). The absolute number of HSCs and MPPs followed similar trends ( Supplementary  Fig. 4 ). HSCs were therefore profoundly depleted by 18 days after pIpC treatment, before pancytopenia was evident.
Lkb1 deletion acutely increased the division of HSCs and MPPs but not most WBM cells. Five days after starting pIpC, Mx1-cre; Lkb1 fl/fl mice and Lkb1 fl/fl controls were administered 5-bromodeoxyuridine (BrdU) for 24 h. We observed a significant increase in BrdU incorporation in HSCs (P , 0.005) and MPPs (P , 0.0005) from Mx1-cre; Lkb1 fl/fl mice ( Fig. 1g and Supplementary Fig. 5a ). This increase in BrdU incorporation within Lkb1-deficient HSCs continued 18 days after pIpC treatment, when HSC depletion was already evident (Supplementary Fig. 5b ). Lkb1-deficiency also significantly (P , 0.05) increased the frequencies of HSCs and MPPs in G1 and S/G2/M phases of the cell cycle ( Fig. 1h and Supplementary Fig. 5c ). In contrast, we observed no effect of Lkb1 deletion on the rate of BrdU incorporation or the frequency of cycling GMPs or WBM cells (Fig. 1g , h and Supplementary Fig. 5a , c).
Lkb1 deletion induced cell death in HSCs. Eleven days after starting pIpC, we observed significant (P , 0.05) increases in caspase activity ( Fig. 1i ) and the frequency of annexin-V 1 4',6-diamidino-2-phenylindole (DAPI) 1 dead cells ( Supplementary Fig. 5d ) in Lkb1-deficient HSCs but not in MPPs, GMPs or WBM cells. Lin 2 Sca-1 1 c-Kit 1 (LSK) cells, GMPs and WBM cells from Lkb1-deficient mice eventually underwent cell death, with significantly (P , 0.05) increased caspase activity 24 days after pIpC treatment ( Fig. 1j ). HSCs therefore depend more acutely on Lkb1 for survival than many other haematopoietic progenitors.
Lkb1-deficient HSCs fail to long-term reconstitute
Lkb1-deficient HSCs failed to long-term multilineage reconstitute irradiated mice. One million donor (CD45.2 1 ) WBM cells from Mx1-cre; Lkb1 fl/fl or Lkb1 fl/fl mice 6 days after starting pIpC treatment were transplanted into irradiated recipient (CD45.1 1 ) mice along with 500,000 recipient cells. Lkb1-deficient cells gave significantly lower levels of overall ( Fig. 2a ), myeloid, B and T ( Supplementary  Fig. 6a -c) lineage reconstitution.
This reflected an autonomous requirement for Lkb1 in HSCs. We transplanted one million donor WBM cells from Mx1-cre; Lkb1 fl/fl mice or Lkb1 fl/fl controls, without pIpC treatment, along with 500,000 wild-type recipient cells into irradiated recipient mice. Six weeks after transplantation, when donor cells had stably engrafted, we treated all the recipients with pIpC. Reconstitution by Mx1-cre; Lkb1 fl/fl cells, but not Lkb1 fl/fl cells, dropped precipitously ( Fig. 2b and Supplementary Fig. 6d -f). The low level of residual reconstitution by Mx1-cre; Lkb1 fl/fl cells was from cells that had not fully deleted Lkb1 ( Supplementary Fig. 7b ). Two months after pIpC treatment we recovered donor HSCs from recipients of Lkb1 fl/fl cells, but not from recipients of Mx1-cre; Lkb1 fl/fl cells ( Fig. 2c ).
Lkb1-deficient HSCs were also unable to form normal colonies in culture. Significantly (P , 0.0005) fewer Lkb1-deficient HSCs formed colonies as compared to control HSCs (Fig. 2d ). The Lkb1-deficient colonies that did form were often much smaller than control colonies , red blood cells (RBC) and platelets (PLT) were significantly depleted in the blood of Lkb1-deficient mice by 24-34 days after pIpC treatment. f, HSC (CD150 1 CD48 2 CD41 2 Lin 2 Sca-1 1 c-Kit 1 ) frequency significantly increased 2-6 days and significantly reduced 18 days after pIpC treatment in Lkb1deficient mice. g, Lkb1-deficient HSCs and MPPs, but not WBM cells, incorporated significantly more BrdU (24-h pulse) 6 days after pIpC treatment. h, Lkb1 deletion drove HSCs and MPPs into cycle, increasing the frequency of these cells in G1 (Ki67 1 cells with 2N DNA content, 2.5-fold, P , 0.05) and S/G2/M phases of the cell cycle (Ki67 1 cells with .2N DNA content, 2.4-fold, P , 0.05) at day 6, but did not affect the cell-cycle distribution of GMPs or WBM cells. i, j, Lkb1-deficient HSCs had significantly increased caspase activity (i, 2.6-fold) at day 11, but other haematopoietic progenitors did not significantly increase caspase activity until day 24 (j). A.U., arbitrary units. 
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( Supplementary Fig. 7a ) and failed to form any secondary colonies upon subcloning ( Supplementary Fig. 5e ). Lkb1-deficient WBM cells also formed significantly fewer colonies (P , 0.005, Fig. 2e ); however, not all colony-forming progenitors required Lkb1. Approximately 50% of sorted GMP cells formed colonies irrespective of whether they were wild type or Lkb1-deficient ( Fig. 2f and Supplementary Fig. 7a ). Complete deletion of Lkb1 was confirmed by western blotting of freshly isolated cells (Fig. 3a ).
mTORC1-independent depletion of Lkb1-deficient HSCs
To test if AMPK was inactivated by Lkb1 deletion, we isolated 30,000 Lin 2 Sca-1 1 c-Kit 1 CD48 2 (LSK48 2 ) cells (highly enriched for HSCs 31 ), LSK48 1 cells (a mixed population of restricted progenitors), GMPs, or WBM cells from Lkb1-deficient and littermate control mice 6 days after pIpC treatment and analysed protein extracts by western blotting. Lkb1 was expressed by each cell population from control mice but not by cells from mutant mice ( Fig. 3a ). AMPKa T172 phosphorylation (the site phosphorylated by Lkb1 (refs 1, 2, 37)) was reduced in Lkb1-deficient LSK48 2 HSCs and to a lesser extent than in LSK48 1 progenitors, but not in GMPs or WBM cells (Fig. 3a) . Phosphorylation of acetyl-CoA carboxylase (ACC), a known substrate of AMPK 37 , was substantially reduced in Lkb1-deficient LSK48 2 HSCs but not in other cell populations 6 days after pIpC treatment (Fig. 3a) . AMPKa T172 and ACC phosphorylation levels were ultimately reduced in Lkb1-deficient WBM cells by 24 days after pIpC treatment (Fig. 3b ). Lkb1 therefore regulates AMPK activation in many haematopoietic cells but HSCs depend more acutely upon Lkb1 for AMPK regulation. AMPK negatively regulates mTOR activation 1,2,37 and increased mTOR activation leads to HSC depletion 36 . We assessed mTORC1 activation based on S6, 4EBP and eIF4G phosphorylation. Phosphorylation of eIF4G did not change significantly after Lkb1 deletion in any population (Fig. 3a ). Phospho-S6 and phospho-4EBP levels increased in Lkb1-deficient LSK48 1 restricted progenitors, GMPs and WBM cells but not in Lkb1-deficient LSK48 2 HSCs (Fig. 3a ). Lkb1-AMPK signalling is either not required to regulate mTORC1 in HSCs or mTORC1 activity in Lkb1-deficient HSCs reflects a complex balance of effects on AMPK/TSC activation versus mitochondrial function/ATP levels 38 . Either way, Lkb1 seems to regulate phosphatidylinositol-3-kinase-mTORC1 pathway signalling differently in HSCs as compared to many other haematopoietic progenitors.
To test whether mTOR activation contributes to HSC depletion, we tested whether rapamycin could rescue the depletion of Lkb1deficient HSCs. Mx1-cre; Lkb1 fl/fl mice and Lkb1 fl/fl controls were treated with pIpC, then injected daily with rapamycin for 2 weeks or 1 month. Rapamycin treatment increased HSC frequency in both wild-type and Lkb1-deficient mice after 2 weeks but rapamycin did not rescue the depletion of HSCs 1 month after Lkb1 deletion (Fig. 3c) . We also transplanted one million Mx1-cre; Lkb1 fl/fl or Lkb1 fl/fl WBM cells into irradiated mice along with 500,000 recipient WBM cells. We treated the recipient mice with pIpC 6 weeks later then administered rapamycin daily to half of the recipient mice. In contrast to what we observed after Pten deletion 36 , rapamycin did not significantly affect reconstitution levels by Lkb1-deficient cells ( Fig. 3d and Supplementary Fig. 6g -i). Our data indicate that increased mTOR activation is not a major mediator of HSC depletion after Lkb1 deletion.
These results were confirmed using tamoxifen-inducible Ubc-cre-ERT2; Lkb1 fl/fl mice 39 . Tamoxifen-induced deletion of Lkb1 led to a rapid loss of donor cell reconstitution that was not attenuated by rapamycin treatment (Fig. 3e and Supplementary Fig. 6j-l) . The depletion of Lkb1-deficient HSCs therefore does not require pIpC.
Lkb1 regulates HSC mitochondrial function
Prkaa1 and Prkaa2, which encode the two catalytic a-subunits of AMPK, were more highly expressed in various haematopoietic stem/progenitor cell populations than in unfractionated WBM cells ( Supplementary Fig. 8a, b) . To test whether AMPK regulates HSC function, we generated floxed alleles of both catalytic subunits of AMPK (Prkaa1 fl and Prkaa2 fl ; Supplementary Fig. 9 ). pIpC-treated Mx1-cre; Prkaa1 fl/fl ; Prkaa2 fl/fl mice are hereafter described as AMPKdeficient mice (Mx1-cre; AMPKa1/a2 fl/fl or AMPKa 2/2 ) for simplicity. After pIpC treatment, AMPKa expression, AMPK T172 phosphorylation and ACC phosphorylation were significantly reduced in all cell populations analysed from Mx1-cre; AMPKa1/a2 fl/fl mice (Fig. 4a) . In contrast to Lkb1, AMPK deletion increased phospho-S6 levels in all populations including LKS48 2 HSCs, LSK48 1 restricted progenitors, GMPs and WBM cells. These results indicate that AMPK negatively regulates mTORC1 signalling in many haematopoietic stem and progenitor cells. 
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Elevated reactive oxygen species (ROS) contribute to HSC depletion in Foxo-deficient mice 40, 41 . However, neither Lkb1 deletion nor AMPK deletion significantly affected ROS levels, measured by 29-79dichlorofluorescein diacetate staining 11 days after pIpC treatment (Fig. 4b, c) . Oxidative stress contributed little to the depletion of Lkb1-deficient HSCs as N-acetyl-cysteine (NAC) treatment of Mx1cre; Lkb1 fl/fl mice did not rescue HSC depletion (Fig. 4d ).
Mitochondria were misregulated in Lkb1-deficient and AMPKdeficient haematopoietic cells. Eleven days after pIpC treatment, mitochondrial mass was significantly (P , 0.05) increased in both Lkb1-deficient and AMPK-deficient HSCs (Fig. 4f, g) . This could reflect negative regulation of mitochondrial mass by Lkb1-AMPK or a compensatory expansion of mitochondria in response to mitochondrial dysfunction and ATP depletion, as observed with Tfam deficiency 42 . Consistent with the latter possibility, we observed a significant reduction in mitochondrial DNA copy number in both Lkb1deficient and AMPK-deficient HSCs 6 days after pIpC treatment (Fig. 4e) , as observed in Tfam-deficient cells 42 . We also observed a significant (P , 0.05) reduction in mitochondrial membrane potential (Dy) within Lkb1-deficient HSCs but not in AMPK-deficient HSCs (Fig. 4i, j) . This reduction in Dy was not observed in Lkb1-deficient GMPs or WBM cells (Fig. 4j, k) . It is formally possible that the reduction in Dy in Lkb1-deficient HSCs was caused by the induction of apoptosis. However, we did not observe reduced Dy in early apoptotic cells (annexin-V 1 DAPI 2 ) compared to cells that showed no sign of initiating cell death (annexin-V 2 DAPI 2 ) ( Supplementary Fig. 11a ).
These results indicate that Lkb1 regulates mitochondrial function by AMPK-dependent and AMPK-independent mechanisms.
To test ATP levels we sorted live cells from each population to ensure that ATP levels were not confounded by the presence of dead cells or debris, and to normalize ATP levels on a per cell basis. At 6 and 11 days after starting pIpC treatment, we observed a 10-15% reduction in cellular ATP levels in Lkb1-deficient HSCs (P , 0.05; Fig. 4h ) but not in Lkb1-deficient MPPs and GMPs ( Supplementary Fig. 11b ). AMPK-deficient HSCs also had significantly reduced levels of ATP 11 days after pIpC treatment (P , 0.005) (Fig. 4h) . The Lkb1-AMPK pathway is thus required for mitochondrial function and energy homeostasis in HSCs.
Although AMPK deficiency phenocopied some of the effects of Lkb1 deficiency in HSCs, AMPK was not required for HSC maintenance. We did not observe a transient increase (day 6) or a rapid depletion (day 18) of HSCs after pIpC treatment of Mx1-cre; AMPKa1/a2 fl/fl mice (Fig. 4l ). We did, however, observe a twofold reduction in HSC frequency in AMPK-deficient mice 70 days after pIpC treatment (P , 0.05, Fig. 4l ). AMPK-deficient HSCs also gave long-term multilineage reconstitution ( Fig. 4m and Supplementary Fig. 10 ). We confirmed that the reconstituting cells in these experiments were AMPKdeficient (data not shown). This indicates that Lkb1 promotes HSC maintenance through mechanisms that are largely AMPK-independent.
Lkb1-deficient HSCs become aneuploid
To examine carefully HSC division we sorted HSCs from Mx1-cre; Lkb1 fl/fl mice and Lkb1 fl/fl controls into culture after pIpC treatment. Almost all HSCs, regardless of Lkb1, divided during the first 3 days of culture (Fig. 5a ). However, wild-type HSCs subsequently expanded geometrically, whereas Lkb1-deficient HSCs exhibited little further division (Fig. 5b) . The limited size of Lkb1-deficient HSC colonies was not due to reduced cell-cycle entry as wild-type and Lkb1-deficient colonies contained similar frequencies of BrdU 1 cells after a 1-h pulse on the third day of culture (Fig. 5c ). Instead, Lkb1-deficient colonies contained significantly (P , 0.05) fewer cells that stained positively for the mitosis marker phospho-histone H3 (Fig. 5d ). This indicated that Lkb1-deficient HSCs were often unable to enter mitosis or they failed to complete mitosis owing to cell death.
Notably, many (32 6 9%) of the mitotic cells within Lkb1-deficient HSC colonies had supernumerary centrosomes and aberrant mitotic spindles, phenotypes not observed in control HSC colonies (Fig. 5e ). We did not observe supernumerary centrosomes or aberrant mitotic spindles in GMPs (data not shown). This raised the possibility that many Lkb1-deficient HSCs may die or produce aneuploid progeny. Indeed, Lkb1-deficient HSC colonies, but not GMP colonies, contained significantly more annexin-V 1 cells and dead cells (Fig. 5f, g) . Although cells in colonies formed by wild-type (LSK) stem/progenitor cells rarely (6.3 6 6.1%) had abnormal chromosome numbers, cells in Lkb1-deficient colonies were often (40.5 6 19.9%) aneuploid AMPKa deletion significantly increased mitochondrial mass in all populations 11 days after pIpC treatment. A representative histogram shows Mitotracker staining in HSCs after Lkb1 or AMPKa deletion (f). h, ATP levels were significantly reduced in HSCs after Lkb1 or AMPKa deletion, 6 or 11 days after pIpC treatment. i-k, Mitochondrial membrane potential (DY) was significantly reduced after Lkb1 deletion in HSCs (i, j) and MPPs but not in WBM cells (j) or GMPs (k) 11 days after pIpC treatment. AMPKa deletion did not reduce DY in any cell population (i, j). l, AMPKa deletion did not cause transient expansion or rapid depletion of HSCs, but did modestly reduce HSC frequency 70 days after pIpC treatment (P , 0.05). m, AMPKa-deficient HSCs were capable of long-term multilineage reconstitution 6 days after pIpC treatment, in contrast to Lkb1-deficient HSCs (Fig. 2a, b ). All data (mean 6 s.d.) are from 3-7 independent experiments.
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(P , 0.0005, Fig. 5h, i) . Lkb1-deficient GMPs from the same mice did not show a significant increase in aneuploidy ( Fig. 5j , P 5 0.75), consistent with their ability to form normal colonies in culture (Fig. 2f ). AMPK-deficient LSK cells also did not show increased aneuploidy (Fig. 5k ), indicating that Lkb1 regulates chromosome stability through AMPK-independent pathways.
Discussion
Consistent with our results, two accompanying papers 43,44 also concluded that Lkb1 is autonomously required for cell-cycle regulation, survival, mitochondrial function and energy homeostasis in HSCs and that HSCs depend more acutely on Lkb1 than many other haematopoietic cells. Fig. 3 ). HSCs were more rapidly depleted after Lkb1 deletion (Fig. 1f ) than after Pten 36 or Foxo 41 deletion. Whereas the mTOR inhibitor rapamycin and/or the anti-oxidant NAC rescued the depletion of Pten-deficient HSCs 36 and Foxo-deficient HSCs 41 , they failed to rescue the depletion of Lkb1-deficient HSCs (Figs 3c-e and 4d ). Lkb1-deficient HSCs are therefore depleted by mechanisms that do not depend on increased mTOR activation or ROS levels. Lkb1 also regulated energy metabolism and mitochondrial function in HSCs through AMPK-dependent and AMPK-independent mechanisms. However, whereas Lkb1 deficiency and AMPK deficiency both reduced ATP levels in HSCs, AMPK deficiency had much less effect on HSC frequency or function. Lkb1 also maintained chromosome stability in HSCs through AMPK-independent mechanisms, as AMPK-deficient primitive progenitors did not show increased aneuploidy (Fig. 5k ). It is unclear whether Lkb1 prevents aneuploidy by regulating mitosis or whether the mitotic defects were secondary to other defects, such as in mitotic entry 45 . Our results indicate that in adult mammals, Lkb1 promotes stem-cell maintenance and tissue regeneration by regulating energy metabolism and by preventing aneuploidy.
METHODS SUMMARY
Mice. Targeting vectors to generate Stk11 tm1Sjm (Lkb1 fl ), Prkaa1 fl and Prkaa2 fl mice were constructed by recombineering 46 (see Supplementary Figs 1 and 9 for details). Bruce4 ES cells 34 were electroporated with the targeting vector and positive clones identified by Southern blotting were injected into blastocysts from C57BL/ 6-Tyr c-2J mice. The resulting male chimaeric mice were bred to female C57BL/ 6-Tyr c-2J mice to obtain germline transmission. The FRT-Neo-FRT cassette was removed by crossing with Flp deleter mice 47 , then the mice were backcrossed at least three additional times onto a C57BL/6 background. C57BL/Ka-Thy-1.1 (CD45.2) and C57BL/Ka-Thy-1.2 (CD45.1) mice were used in transplantation experiments. Mx1-cre mice 35 and Ubc-cre-ERT2 mice 39 were backcrossed onto a C57BL/6 background. All mice were housed in the Unit for Laboratory Animal Medicine at the University of Michigan and treated with procedures approved by the University of Michigan Committee on the Use and Care of Animals. pIpC, rapamycin, N-acetyl-L-cysteine and tamoxifen administration. pIpC (Amersham) was re-suspended in Dulbecco's PBS at 50 mg ml 21 , and mice were injected intraperitoneally (i.p.) with 0.5 mg g 21 of body mass every other day for 6 days. Rapamycin (LC Laboratories) was administered daily by i.p. injection at a dose of 4 mg kg 21 (ref. 36) . N-acetyl-L-cysteine (NAC; Sigma) was administered daily by subcutaneous injection at 100 mg kg 21 (pH 7.0) 41 . Tamoxifen citrate (Spectrum Chemical) was mixed with regular chow at 400 mg kg 21 with 5% sucrose (Teklad) and given to mice starting at the indicated time point. 
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